65.94 -0.13(-0.20%) Date:

AbbVie Inc (ABBV) Can Be Worth $53-78 On Pricing Humira IP: Leerink

Leerink analysts weigh in on different Humira scenarios facing AbbVie

AbbVie Inc (ABBV) A Step Ahead in Leukemia Portfolio

The drug maker has a good window of opportunity to patch up the revenue loss due to patent expiration and biosimilars